FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 44 filers reported holding FINCH THERAPEUTICS GROUP INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $274 | -100.0% | 570,000 | 0.0% | 0.27% | -71.3% |
| Q3 2022 | $952,000 | -41.2% | 570,000 | 0.0% | 0.94% | -7.8% |
| Q2 2022 | $1,619,000 | -43.5% | 570,000 | 0.0% | 1.02% | -35.4% |
| Q1 2022 | $2,867,000 | -49.6% | 570,000 | 0.0% | 1.57% | -14.1% |
| Q4 2021 | $5,683,000 | -23.3% | 570,000 | 0.0% | 1.83% | -31.8% |
| Q3 2021 | $7,410,000 | -4.3% | 570,000 | +3.6% | 2.68% | +52.9% |
| Q2 2021 | $7,739,000 | -11.6% | 550,000 | 0.0% | 1.75% | -47.9% |
| Q1 2021 | $8,751,000 | – | 550,000 | – | 3.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|